Study of Haemodialysis Patients Switching From Aranesp to Biosimilar

CompletedOBSERVATIONAL
Enrollment

272

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

April 30, 2015

Study Completion Date

May 31, 2015

Conditions
Anaemia
Trial Locations (23)

4029

Research Site, Herston

4102

Research Site, Woolloongabba

4560

Research Site, Nambour

8000

Research Site, Burgas

12242

Research Site, Aigáleo

12244

Research Site, Egaleo, Athens

17676

Research Site, Kallithea, Athens

23007

Research Site, Jaén

26225

Research Site, Pátrai

26500

Research Site, Pátrai

32429

Research Site, Minden

32657

Research Site, Lemgo

35423

Research Site, Lich

41335

Research Site, Larissa

49022

Research Site, Zamora

56124

Research Site, Pisa

98057

Research Site, Milazzo ME

89-600

Research Site, Chojnice

80-952

Research Site, Gdansk

31-501

Research Site, Krakow

20-954

Research Site, Lublin

60-355

Research Site, Poznan

44-200

Research Site, Rybnik

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Amgen

INDUSTRY